"Dermatomyositis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
Descriptor ID |
D003882
|
MeSH Number(s) |
C05.651.594.819.500 C10.668.491.562.575.500 C17.300.250 C17.800.185
|
Concept/Terms |
Dermatomyositis- Dermatomyositis
- Dermatomyositides
- Juvenile Myositis
- Juvenile Myositides
- Myositides, Juvenile
- Myositis, Juvenile
- Dermatopolymyositis
- Dermatopolymyositides
- Polymyositis-Dermatomyositis
- Polymyositis Dermatomyositis
- Polymyositis-Dermatomyositides
- Juvenile Dermatomyositis
- Dermatomyositides, Juvenile
- Dermatomyositis, Juvenile
- Juvenile Dermatomyositides
Dermatomyositis, Adult Type- Dermatomyositis, Adult Type
- Adult Type Dermatomyositides
- Adult Type Dermatomyositis
- Dermatomyositides, Adult Type
Dermatomyositis, Childhood Type- Dermatomyositis, Childhood Type
- Childhood Type Dermatomyositides
- Childhood Type Dermatomyositis
- Dermatomyositides, Childhood Type
|
Below are MeSH descriptors whose meaning is more general than "Dermatomyositis".
Below are MeSH descriptors whose meaning is more specific than "Dermatomyositis".
This graph shows the total number of publications written about "Dermatomyositis" by people in this website by year, and whether "Dermatomyositis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 1 | 2 |
2004 | 1 | 0 | 1 |
2005 | 2 | 1 | 3 |
2006 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2010 | 2 | 0 | 2 |
2011 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dermatomyositis" by people in Profiles.
-
Dalakas MC. Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits. Expert Rev Clin Immunol. 2022 04; 18(4):413-423.
-
Kim H, Gunter-Rahman F, McGrath JA, Lee E, de Jesus AA, Targoff IN, Huang Y, O'Hanlon TP, Tsai WL, Gadina M, Miller FW, Goldbach-Mansky R, Rider LG. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies. Arthritis Res Ther. 2020 04 06; 22(1):69.
-
Musumeci G, Castrogiovanni P, Barbagallo I, Tibullo D, Sanfilippo C, Nunnari G, Pellican? GF, Pavone P, Caltabiano R, Di Marco R, Imbesi R, Di Rosa M. Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection. Int J Mol Sci. 2018 Sep 17; 19(9).
-
Fraint E, Leffler M, Schultz CL. Coexisting Juvenile Dermatomyositis and Sickle Cell Disease: Maintaining a High Degree of Suspicion. J Pediatr. 2017 07; 186:189-191.
-
Delman D, Peng X, Zedek DC, Jewells V, Chahin N, Markovic-Plese S. Dermatomyositis as a presentation of neuromyelitis optica spectrum disorder. J Neuroimmunol. 2015 Jan 15; 278:108-11.
-
Dalakas MC. Pathophysiology of inflammatory and autoimmune myopathies. Presse Med. 2011 Apr; 40(4 Pt 2):e237-47.
-
Dalakas MC. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol. 2010 Jun; 10(3):346-52.
-
Dalakas MC. Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol. 2010 Mar; 6(3):129-37.
-
Schmidt J, Barthel K, Wrede A, Salajegheh M, Bähr M, Dalakas MC. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Brain. 2008 May; 131(Pt 5):1228-40.
-
Dalakas MC. Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Neuromuscul Disord. 2006 Apr; 16(4):223-36.